Get the Stockscreener App
166.27
0.24%
0.40
Pre-market:
167.70
1.43
+0.86%
Charles River Laboratories International Inc Stock (CRL) Latest News
E. Ohman J or Asset Management AB Acquires 1,800 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Trust Point Inc. Makes New Investment in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch
Morgan Stanley Adjusts Charles River Laboratories International's Price Target to $184 From $220 - Marketscreener.com
Morgan Stanley Lowers Charles River Laboratories International (NYSE:CRL) Price Target to $184.00 - MarketBeat
Charles River Laboratories stock hits 52-week low at $160.73 - MSN
Boston Trust Walden Corp Purchases 8,338 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
JPMorgan Chase & Co. Issues Pessimistic Forecast for Charles River Laboratories International (NYSE:CRL) Stock Price - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Norris Perne & French LLP MI - MarketBeat
CRL Gears Up for Q4 Earnings: Here's What You Need to Know - MSN
Short Interest in Charles River Laboratories International, Inc. (NYSE:CRL) Rises By 5.6% - MarketBeat
Charles River Laboratories International (NYSE:CRL) Reaches New 12-Month LowShould You Sell? - MarketBeat
Laurus Investment Counsel Inc. Has $14.61 Million Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Stock Position Lowered by Hantz Financial Services Inc. - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Janney Montgomery Scott LLC - MarketBeat
Charles River Laboratories: Retained Earnings, ROE, And Debt Management Will Shape Its Future Amid Weak Demand - Seeking Alpha
High Throughput Screening (HTS) Market to Grow by USD 19.9 Billion (2024-2028), Boosted by Rising R&D Investments, with AI Redefining Market LandscapeTechnavio - Yahoo Finance
Pharma researcher Charles River to close Durham facility, lay off dozens - WRAL News
Fifth Third Bancorp Sells 3,752 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Gmp Cell Banking Services Market Generated Opportunities, - openPR
Charles River Laboratories credit outlook lowered to stable at S&P on weak 2025 guidance - MSN
Clinical Trials Market Outlook: Competitor Insights and Market - openPR
Billion-dollar pharma company to close Triangle sites - The Business Journals
Charles River Laboratories stock hits 52-week low at $160.73 By Investing.com - Investing.com Canada
CRLCharles River Laboratories International, Inc. Latest Stock News & Market Updates - StockTitan
Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call - sharewise
Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Mizuho starts Charles River Labs at neutral, cites near-term challenges - MSN
We Think Charles River Laboratories International (NYSE:CRL) Is Taking Some Risk With Its Debt - Simply Wall St
The Goldman Sachs Group Has Lowered Expectations for Charles River Laboratories International (NYSE:CRL) Stock Price - Defense World
Charles River Laboratories' Quarterly Earnings Preview: What You Need to Know - MSN
Charles River Laboratories International Inc. stock underperforms Friday when compared to competitors - MarketWatch
The Goldman Sachs Group Issues Pessimistic Forecast for Charles River Laboratories International (NYSE:CRL) Stock Price - MarketBeat
Charles River Laboratories' Quarterly Earnings Preview: What You Need To Know - Barchart
Veracity Capital LLC Acquires New Holdings in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Will CRL Stock Gain From Integration of Akron Bio's CSS Product Line? - MSN
Park Avenue Securities LLC Has $514,000 Stake in Charles River Laboratories International, Inc. (NYSE:CRL) - Defense World
William Blair Downgrades Charles River Laboratories International (NYSE:CRL) to Market Perform - Defense World
Charles River Launches Apollo for CRADL to Boost Research, Stock Rises - MSN
What Analysts Are Saying About Charles River Stock - Benzinga
Riverbridge Partners LLC Decreases Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Pharmaceutical Regulatory Affairs Research Report 2025-2030: Entry of Companies into the Global Market Fueling Growth - GlobeNewswire Inc.
Charles River downgraded to Market Perform from Outperform at William Blair - Yahoo Finance
Cell Bank Creation Service Market Overall Study Report - openPR
William Blair cuts Charles River Labs stock rating to Market Perform - Investing.com Australia
What Makes Charles River Labs (CRL) an Investment Bet? - MSN
William Blair Downgrades Charles River Laboratories International (CRL) - MSN
RiverWater Partners Sustainable Value Strategy Trimmed its Investment in Charles River Laboratories (CRL) - MSN
Charles River Labs downgraded at William Blair on less early-stage R&D spending - MSN
Bioanalytical Services Market CAGR to be at 7.1% By 2032 Merck KGaA, WuXi AppTec, Charles River Laboratories, - EIN News
1.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):